High-dose-rate brachytherapy improves quality of life in prostate cancerJuly 28, 2021Hepatocellular Carcinoma
Enzalutamide tops abiraterone acetate for progression-free survival in metastatic prostate cancerJuly 28, 2021Hepatocellular Carcinoma
Black men may have an increased risk of prostate cancer progression on active surveillanceJuly 28, 2021Hepatocellular Carcinoma
Inflammatory response in prostate cancer shows variation by ethnicityJuly 28, 2021Hepatocellular Carcinoma
Docetaxel demonstrates stronger safety and survival profile than cabazitaxel for prostate cancerJuly 28, 2021Hepatocellular Carcinoma
Active surveillance does not impair quality of life in low-risk prostate cancerJuly 28, 2021Hepatocellular Carcinoma
Platelet-to-lymphocyte ratio fails to predict prostate cancer at biopsyJuly 28, 2021Hepatocellular Carcinoma
IBD patients with prostate cancer may benefit from radiation therapyJuly 28, 2021Hepatocellular Carcinoma
Liver resection yields limited success in HCC patients with hepatitis B/C coinfectionJuly 26, 2021Hepatocellular Carcinoma
Laparoscopic repeat liver resection shows safety for recurrent HCC patientsJuly 26, 2021Hepatocellular Carcinoma
Anatomical liver resection surpasses nonanatomical resection for overall survival in HCCJuly 26, 2021Hepatocellular Carcinoma
Lenvatinib extends time to disease progression in HCC patients with portal vein tumor thrombusJuly 26, 2021Hepatocellular Carcinoma
